Innovation

Encapsulation of Aqueous Phase Systems within Microscopic Volumes

The Pennsylvania State University
posted on 02/16/2010

The disclosed invention relates to the construction and characterization of synthetic cells that mimic not only the plasma membrane of eukaryotic cells, but also the presence of cytoplasm and internal structures. Operating under the assumption that the macromolecular reactivity, macromolecular crowding, and volume exclusion characteristics of living cells can be replicated and controlled in non-living systems (i.e. synthetic cells), Penn State researchers have methodized the production of two unique vessel compartments: unilamellar liposomes and lithographically-defined depressions in solid substrates.

Advantages

  • Compartment scale ranges from nanoscale (1-1000 nm) to “cell-sized” (1-100 microns)
  • Nanoscale compartments allow for an increase in macromolecule volumetric concentrations.
  • Lithographically-defined compartments offer increased control over the spatial location of aqueous phases.

Innovation Details
 

Detailed Description

Background
Macromolecule crowding—and the changes in macromolecule behavior and reactivity observed therein—has been proposed as an important, nonspecific biophysical phenomena with likely evolutionary effects on the organizational functioning of cellular signaling complexes. Recent interest in molecular crowding has led researchers to question the manner in which synthetic cell structures can be used to determine the importance of confinement and volume exclusion on cell behavior. While previous studies involving synthetic cells (or “compartments”) have shed light on macromolecular reactions within liposomes, studies of reaction rates outside the vesicles have yet to be performed. Furthermore, prior generations of synthetic cell reaction vessels were physically larger than naturally-occurring molecular dimensions. As such, more advanced and nuanced materials and assays are needed to fully exploit the potential of synthetic compartments.

Invention Description
The disclosed invention relates to the construction and characterization of synthetic cells that mimic not only the plasma membrane of eukaryotic cells, but also the presence of cytoplasm and internal structures. Operating under the assumption that the macromolecular reactivity, macromolecular crowding, and volume exclusion characteristics of living cells can be replicated and controlled in non-living systems (i.e. synthetic cells), Penn State researchers have methodized the production of two unique vessel compartments: unilamellar liposomes and lithographically-defined depressions in solid substrates. When filled with aqueous solutions containing high concentrations of macromolecules, these synthetic cells can aid in understanding the biomechanics of cellular functions, such as phase separation.

Lithographically–defined compartments offer the advantage of being readily engineered in different shapes and sizes. The ability to manipulate cell shape and volume allows for the direct study of how surface area ratios affect the phase separation behavior of the vessel. Though not as readily derivatized or mass-produced as identical test-structures, membrane-bounded unilamellar liposomes are more accurate models of eukaryotic biology than lithographically-defined compartments. Together, these compartments represent the next generation of synthetic cell technology.

File Number: 2635 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Matthew Smith at The Pennsylvania State University for more information.

Request more info via email request more info
People

Case Manager:

Matthew Smith Matthew Smith

Innovations (113)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,840 members 17,176 innovations 152 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...